Advanced HIV Re-engagement in Care
ConditionAdvanced HIV Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham
About this trial
Adults who are hospitalized in Lusaka, Zambia, and found to have advanced HIV disease will be enrolled and randomly assigned to receive the ARC intervention or standard of care. All participants will then be followed through the end of the hospitalization and for up to 1 year after discharge from hospital.
Eligibility criteria
Qualifiers
Living with HIV
Advanced HIV defined as CD4 <350 cells/mm3 or WHO stage 3 or 4 event
Currently admitted to study hospital's internal medicine department
Disqualifiers
Planning to reside outside Lusaka after discharge
Too sick to provide informed consent
Known to have advanced cancer (defined as requiring chemo/radiation therapy or referred to hospice) other than Kaposi Sarcoma
Known to have end stage kidney disease
Trial design
Treatments tested in this trial
- ARC
Treatment groups
724 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Alabama at Birmingham
Lead sponsor
Ciheb Zambia
Collaborator
University of Maryland, Baltimore
Collaborator
Source ClinicalTrials.gov